Search Results
Slidesets
Innate immune responses to HCV Infection - Kui Li, MD
Presented at:
Asian Conference on Hepatitis and AIDS (ACHA) 2014
Slidesets
Clinical Pharmacology of Integrase Inhibitors - Giovanni Di Perri, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2018
Slidesets
Richard Elion | Long-Acting Drugs for PrEP
Presented at:
Rio de Janeiro HIV Clinical Forum 2020
Abstracts
Impact of SARS-CoV-2 omicron and delta sub-lineage AY.4.2 variant on neutralization by sera of patients treated with different licensed monoclonal antibodies
L. Fiaschi
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Epidemiological and clinical features of SARS-CoV-2 variants circulating between April- December 2021 in Italy
C. Ventura
Reviews in Antiviral Therapy & Infectious Diseases 3, 2022
Presented at:
European Meeting on HIV & Hepatitis 2022
Abstracts
Creation of an Italian HIV DNA Network for the validation and clinical use of HIV-1 DNA quantification assays
I. Vicenti
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Prevalence of transmitted resistance mutations to rilpivirine and doravirine in treatment-naive patients in a large clinical and resistance database
F. Lombardi
Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Slidesets
Microbial dysbiosis does not alter immune activation or disease progression in SIV-infected rhesus macaques- Alexandra Ortiz
Presented at:
International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017
Slidesets
Early Cellular Targets of HIV Infections - Anthony Cunningham, AO, FAHMS, MD, FRACP, FRCPA
Presented at:
International Workshop on HIV Transmission 2020